Home > Insider Trading > Filing (0001415889-24-023812)

Filing Details

Accession Number:: 0001415889-24-023812
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-20 21:35:04
Reporting Period:: 2024-09-18

Accepted Time:: 2024-09-20 21:35:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646649	Jonathan Sheena	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-09-18	1,922	$127.38	285,519	No	4	S	Direct
Common Stock	Disposition	2024-09-18	778	$128.06	284,741	No	4	S	Direct
Common Stock	Disposition	2024-09-18	6,404	$127.38	62,178	No	4	S	Indirect	By Caraluna 1 Trust
Common Stock	Disposition	2024-09-18	3,246	$128.06	58,932	No	4	S	Indirect	By Caraluna 1 Trust
Common Stock	Disposition	2024-09-18	6,584	$127.39	61,998	No	4	S	Indirect	By Caraluna 2 Trust
Common Stock	Disposition	2024-09-18	3,066	$128.07	58,932	No	4	S	Indirect	By Caraluna 2 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Caraluna 1 Trust
No	4	S	Indirect	By Caraluna 1 Trust
No	4	S	Indirect	By Caraluna 2 Trust
No	4	S	Indirect	By Caraluna 2 Trust

Footnotes

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.85 to $128.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.8400 to $128.3250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7800 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.8100 to $128.2650 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.